Detalles de la búsqueda
1.
Nivolumab in sorafenib-naive and sorafenib-experienced patients with advanced hepatocellular carcinoma: 5-year follow-up from CheckMate 040.
Ann Oncol;
35(4): 381-391, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38151184
2.
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Ann Oncol;
35(5): 448-457, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38382875
3.
Circulating tumor DNA analysis of the phase III VOYAGER trial: KIT mutational landscape and outcomes in patients with advanced gastrointestinal stromal tumor treated with avapritinib or regorafenib.
Ann Oncol;
34(7): 615-625, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37105265
4.
[Application value of DNA damage repair variants in adjuvant therapy of triple negative breast cancer].
Zhonghua Zhong Liu Za Zhi;
45(9): 787-795, 2023 Sep 23.
Artículo
en Zh
| MEDLINE | ID: mdl-37805443
5.
Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors: first-in-human dose-escalation study.
Ann Oncol;
33(4): 416-425, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35026412
6.
[The prospects of DNA damage repair variants guiding platinum compounds in the treatment of triple negative breast cancer].
Zhonghua Zhong Liu Za Zhi;
44(1): 68-72, 2022 Jan 23.
Artículo
en Zh
| MEDLINE | ID: mdl-35073650
7.
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network.
Ann Oncol;
31(11): 1506-1517, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32891793
8.
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4).
Ann Oncol;
30(2): 250-258, 2019 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30566590
9.
Efficacy and safety findings from DREAM: a phase III study of DHP107 (oral paclitaxel) versus i.v. paclitaxel in patients with advanced gastric cancer after failure of first-line chemotherapy.
Ann Oncol;
29(5): 1220-1226, 2018 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29438463
10.
Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma.
Ann Oncol;
26(12): 2457-63, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26386123
11.
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).
Ann Oncol;
26(10): 2097-101, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26216386
12.
A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer.
Br J Cancer;
111(4): 660-6, 2014 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-24960402
13.
Analysis of serum protein biomarkers, circulating tumor DNA, and dovitinib activity in patients with tyrosine kinase inhibitor-refractory gastrointestinal stromal tumors.
Ann Oncol;
25(11): 2272-2277, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25149706
14.
IL-23 promotes osteoclastogenesis in osteoblast-osteoclast co-culture system.
Genet Mol Res;
13(2): 4673-9, 2014 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-25036517
15.
Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib.
Br J Cancer;
109(9): 2309-15, 2013 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-24084771
16.
Adjuvant chemotherapy for gastric cancer: a randomised phase 3 trial of mitomycin-C plus either short-term doxifluridine or long-term doxifluridine plus cisplatin after curative D2 gastrectomy (AMC0201).
Br J Cancer;
108(6): 1245-51, 2013 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-23449357
17.
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma.
Ann Oncol;
24(6): 1567-73, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23406728
18.
Aberrant methylation of donor genome in cloned bovine embryos.
Nat Genet;
28(2): 173-7, 2001 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-11381267
19.
Fiber reinforced hydrated networks recapitulate the poroelastic mechanics of articular cartilage.
Acta Biomater;
167: 69-82, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37331613
20.
Phase II study of everolimus with biomarker exploration in patients with advanced gastric cancer refractory to chemotherapy including fluoropyrimidine and platinum.
Br J Cancer;
106(6): 1039-44, 2012 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-22343617